Global Testosterone Injectable Market Growth 2024-2030
The report requires updating with new data and is sent in 48 hours after order is placed.
The global Testosterone Injectable market size is projected to grow from US$ million in 2024 to US$ million in 2030; it is expected to grow at a CAGR of %from 2024 to 2030.
LP Information, Inc. (LPI) ' newest research report, the “Testosterone Injectable Industry Forecast” looks at past sales and reviews total world Testosterone Injectable sales in 2023, providing a comprehensive analysis by region and market sector of projected Testosterone Injectable sales for 2024 through 2030. With Testosterone Injectable sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Testosterone Injectable industry.
This Insight Report provides a comprehensive analysis of the global Testosterone Injectable landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Testosterone Injectable portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Testosterone Injectable market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Testosterone Injectable and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Testosterone Injectable.
United States market for Testosterone Injectable is estimated to increase from US$ million in 2023 to US$ million by 2030, at a CAGR of % from 2024 through 2030.
China market for Testosterone Injectable is estimated to increase from US$ million in 2023 to US$ million by 2030, at a CAGR of % from 2024 through 2030.
Europe market for Testosterone Injectable is estimated to increase from US$ million in 2023 to US$ million by 2030, at a CAGR of % from 2024 through 2030.
Global key Testosterone Injectable players cover Clarus Therapeutics, Bayer, Endo Pharmaceuticals, Eli Lilly and Company, Kyowa Kirin International, etc. In terms of revenue, the global two largest companies occupied for a share nearly
% in 2023.
This report presents a comprehensive overview, market shares, and growth opportunities of Testosterone Injectable market by product type, application, key manufacturers and key regions and countries.
Segmentation by Type:
What is the 10-year outlook for the global Testosterone Injectable market?
What factors are driving Testosterone Injectable market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Testosterone Injectable market opportunities vary by end market size?
How does Testosterone Injectable break out by Type, by Application?
The global Testosterone Injectable market size is projected to grow from US$ million in 2024 to US$ million in 2030; it is expected to grow at a CAGR of %from 2024 to 2030.
LP Information, Inc. (LPI) ' newest research report, the “Testosterone Injectable Industry Forecast” looks at past sales and reviews total world Testosterone Injectable sales in 2023, providing a comprehensive analysis by region and market sector of projected Testosterone Injectable sales for 2024 through 2030. With Testosterone Injectable sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Testosterone Injectable industry.
This Insight Report provides a comprehensive analysis of the global Testosterone Injectable landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Testosterone Injectable portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Testosterone Injectable market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Testosterone Injectable and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Testosterone Injectable.
United States market for Testosterone Injectable is estimated to increase from US$ million in 2023 to US$ million by 2030, at a CAGR of % from 2024 through 2030.
China market for Testosterone Injectable is estimated to increase from US$ million in 2023 to US$ million by 2030, at a CAGR of % from 2024 through 2030.
Europe market for Testosterone Injectable is estimated to increase from US$ million in 2023 to US$ million by 2030, at a CAGR of % from 2024 through 2030.
Global key Testosterone Injectable players cover Clarus Therapeutics, Bayer, Endo Pharmaceuticals, Eli Lilly and Company, Kyowa Kirin International, etc. In terms of revenue, the global two largest companies occupied for a share nearly
% in 2023.
This report presents a comprehensive overview, market shares, and growth opportunities of Testosterone Injectable market by product type, application, key manufacturers and key regions and countries.
Segmentation by Type:
- Testosterone Cypionate
- Testosterone Undecanoate
- Testosterone Enanthate
- Methyl testosterone
- Others
- Hospitals
- Homecare
- Specialty Clinics
- Others
- Americas
- United States
- Canada
- Mexico
- Brazil
- APAC
- China
- Japan
- Korea
- Southeast Asia
- India
- Australia
- Europe
- Germany
- France
- UK
- Italy
- Russia
- Middle East & Africa
- Egypt
- South Africa
- Israel
- Turkey
- GCC Countries
- Clarus Therapeutics
- Bayer
- Endo Pharmaceuticals
- Eli Lilly and Company
- Kyowa Kirin International
- Viatris
- Novartis
- Pfizer
- J & K Scientific
- Beijing Coupling Technology
- Longyan Tianhua Biological Technology
What is the 10-year outlook for the global Testosterone Injectable market?
What factors are driving Testosterone Injectable market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Testosterone Injectable market opportunities vary by end market size?
How does Testosterone Injectable break out by Type, by Application?
1 SCOPE OF THE REPORT
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Testosterone Injectable Annual Sales 2019-2030
2.1.2 World Current & Future Analysis for Testosterone Injectable by Geographic Region, 2019, 2023 & 2030
2.1.3 World Current & Future Analysis for Testosterone Injectable by Country/Region, 2019, 2023 & 2030
2.2 Testosterone Injectable Segment by Type
2.2.1 Testosterone Cypionate
2.2.2 Testosterone Undecanoate
2.2.3 Testosterone Enanthate
2.2.4 Methyl testosterone
2.2.5 Others
2.3 Testosterone Injectable Sales by Type
2.3.1 Global Testosterone Injectable Sales Market Share by Type (2019-2024)
2.3.2 Global Testosterone Injectable Revenue and Market Share by Type (2019-2024)
2.3.3 Global Testosterone Injectable Sale Price by Type (2019-2024)
2.4 Testosterone Injectable Segment by Application
2.4.1 Hospitals
2.4.2 Homecare
2.4.3 Specialty Clinics
2.4.4 Others
2.5 Testosterone Injectable Sales by Application
2.5.1 Global Testosterone Injectable Sale Market Share by Application (2019-2024)
2.5.2 Global Testosterone Injectable Revenue and Market Share by Application (2019-2024)
2.5.3 Global Testosterone Injectable Sale Price by Application (2019-2024)
3 GLOBAL BY COMPANY
3.1 Global Testosterone Injectable Breakdown Data by Company
3.1.1 Global Testosterone Injectable Annual Sales by Company (2019-2024)
3.1.2 Global Testosterone Injectable Sales Market Share by Company (2019-2024)
3.2 Global Testosterone Injectable Annual Revenue by Company (2019-2024)
3.2.1 Global Testosterone Injectable Revenue by Company (2019-2024)
3.2.2 Global Testosterone Injectable Revenue Market Share by Company (2019-2024)
3.3 Global Testosterone Injectable Sale Price by Company
3.4 Key Manufacturers Testosterone Injectable Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Testosterone Injectable Product Location Distribution
3.4.2 Players Testosterone Injectable Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2019-2024)
3.6 New Products and Potential Entrants
3.7 Market M&A Activity & Strategy
4 WORLD HISTORIC REVIEW FOR TESTOSTERONE INJECTABLE BY GEOGRAPHIC REGION
4.1 World Historic Testosterone Injectable Market Size by Geographic Region (2019-2024)
4.1.1 Global Testosterone Injectable Annual Sales by Geographic Region (2019-2024)
4.1.2 Global Testosterone Injectable Annual Revenue by Geographic Region (2019-2024)
4.2 World Historic Testosterone Injectable Market Size by Country/Region (2019-2024)
4.2.1 Global Testosterone Injectable Annual Sales by Country/Region (2019-2024)
4.2.2 Global Testosterone Injectable Annual Revenue by Country/Region (2019-2024)
4.3 Americas Testosterone Injectable Sales Growth
4.4 APAC Testosterone Injectable Sales Growth
4.5 Europe Testosterone Injectable Sales Growth
4.6 Middle East & Africa Testosterone Injectable Sales Growth
5 AMERICAS
5.1 Americas Testosterone Injectable Sales by Country
5.1.1 Americas Testosterone Injectable Sales by Country (2019-2024)
5.1.2 Americas Testosterone Injectable Revenue by Country (2019-2024)
5.2 Americas Testosterone Injectable Sales by Type (2019-2024)
5.3 Americas Testosterone Injectable Sales by Application (2019-2024)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Testosterone Injectable Sales by Region
6.1.1 APAC Testosterone Injectable Sales by Region (2019-2024)
6.1.2 APAC Testosterone Injectable Revenue by Region (2019-2024)
6.2 APAC Testosterone Injectable Sales by Type (2019-2024)
6.3 APAC Testosterone Injectable Sales by Application (2019-2024)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 EUROPE
7.1 Europe Testosterone Injectable by Country
7.1.1 Europe Testosterone Injectable Sales by Country (2019-2024)
7.1.2 Europe Testosterone Injectable Revenue by Country (2019-2024)
7.2 Europe Testosterone Injectable Sales by Type (2019-2024)
7.3 Europe Testosterone Injectable Sales by Application (2019-2024)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Testosterone Injectable by Country
8.1.1 Middle East & Africa Testosterone Injectable Sales by Country (2019-2024)
8.1.2 Middle East & Africa Testosterone Injectable Revenue by Country (2019-2024)
8.2 Middle East & Africa Testosterone Injectable Sales by Type (2019-2024)
8.3 Middle East & Africa Testosterone Injectable Sales by Application (2019-2024)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 MANUFACTURING COST STRUCTURE ANALYSIS
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Testosterone Injectable
10.3 Manufacturing Process Analysis of Testosterone Injectable
10.4 Industry Chain Structure of Testosterone Injectable
11 MARKETING, DISTRIBUTORS AND CUSTOMER
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Testosterone Injectable Distributors
11.3 Testosterone Injectable Customer
12 WORLD FORECAST REVIEW FOR TESTOSTERONE INJECTABLE BY GEOGRAPHIC REGION
12.1 Global Testosterone Injectable Market Size Forecast by Region
12.1.1 Global Testosterone Injectable Forecast by Region (2025-2030)
12.1.2 Global Testosterone Injectable Annual Revenue Forecast by Region (2025-2030)
12.2 Americas Forecast by Country (2025-2030)
12.3 APAC Forecast by Region (2025-2030)
12.4 Europe Forecast by Country (2025-2030)
12.5 Middle East & Africa Forecast by Country (2025-2030)
12.6 Global Testosterone Injectable Forecast by Type (2025-2030)
12.7 Global Testosterone Injectable Forecast by Application (2025-2030)
13 KEY PLAYERS ANALYSIS
13.1 Clarus Therapeutics
13.1.1 Clarus Therapeutics Company Information
13.1.2 Clarus Therapeutics Testosterone Injectable Product Portfolios and Specifications
13.1.3 Clarus Therapeutics Testosterone Injectable Sales, Revenue, Price and Gross Margin (2019-2024)
13.1.4 Clarus Therapeutics Main Business Overview
13.1.5 Clarus Therapeutics Latest Developments
13.2 Bayer
13.2.1 Bayer Company Information
13.2.2 Bayer Testosterone Injectable Product Portfolios and Specifications
13.2.3 Bayer Testosterone Injectable Sales, Revenue, Price and Gross Margin (2019-2024)
13.2.4 Bayer Main Business Overview
13.2.5 Bayer Latest Developments
13.3 Endo Pharmaceuticals
13.3.1 Endo Pharmaceuticals Company Information
13.3.2 Endo Pharmaceuticals Testosterone Injectable Product Portfolios and Specifications
13.3.3 Endo Pharmaceuticals Testosterone Injectable Sales, Revenue, Price and Gross Margin (2019-2024)
13.3.4 Endo Pharmaceuticals Main Business Overview
13.3.5 Endo Pharmaceuticals Latest Developments
13.4 Eli Lilly and Company
13.4.1 Eli Lilly and Company Company Information
13.4.2 Eli Lilly and Company Testosterone Injectable Product Portfolios and Specifications
13.4.3 Eli Lilly and Company Testosterone Injectable Sales, Revenue, Price and Gross Margin (2019-2024)
13.4.4 Eli Lilly and Company Main Business Overview
13.4.5 Eli Lilly and Company Latest Developments
13.5 Kyowa Kirin International
13.5.1 Kyowa Kirin International Company Information
13.5.2 Kyowa Kirin International Testosterone Injectable Product Portfolios and Specifications
13.5.3 Kyowa Kirin International Testosterone Injectable Sales, Revenue, Price and Gross Margin (2019-2024)
13.5.4 Kyowa Kirin International Main Business Overview
13.5.5 Kyowa Kirin International Latest Developments
13.6 Viatris
13.6.1 Viatris Company Information
13.6.2 Viatris Testosterone Injectable Product Portfolios and Specifications
13.6.3 Viatris Testosterone Injectable Sales, Revenue, Price and Gross Margin (2019-2024)
13.6.4 Viatris Main Business Overview
13.6.5 Viatris Latest Developments
13.7 Novartis
13.7.1 Novartis Company Information
13.7.2 Novartis Testosterone Injectable Product Portfolios and Specifications
13.7.3 Novartis Testosterone Injectable Sales, Revenue, Price and Gross Margin (2019-2024)
13.7.4 Novartis Main Business Overview
13.7.5 Novartis Latest Developments
13.8 Pfizer
13.8.1 Pfizer Company Information
13.8.2 Pfizer Testosterone Injectable Product Portfolios and Specifications
13.8.3 Pfizer Testosterone Injectable Sales, Revenue, Price and Gross Margin (2019-2024)
13.8.4 Pfizer Main Business Overview
13.8.5 Pfizer Latest Developments
13.9 J & K Scientific
13.9.1 J & K Scientific Company Information
13.9.2 J & K Scientific Testosterone Injectable Product Portfolios and Specifications
13.9.3 J & K Scientific Testosterone Injectable Sales, Revenue, Price and Gross Margin (2019-2024)
13.9.4 J & K Scientific Main Business Overview
13.9.5 J & K Scientific Latest Developments
13.10 Beijing Coupling Technology
13.10.1 Beijing Coupling Technology Company Information
13.10.2 Beijing Coupling Technology Testosterone Injectable Product Portfolios and Specifications
13.10.3 Beijing Coupling Technology Testosterone Injectable Sales, Revenue, Price and Gross Margin (2019-2024)
13.10.4 Beijing Coupling Technology Main Business Overview
13.10.5 Beijing Coupling Technology Latest Developments
13.11 Longyan Tianhua Biological Technology
13.11.1 Longyan Tianhua Biological Technology Company Information
13.11.2 Longyan Tianhua Biological Technology Testosterone Injectable Product Portfolios and Specifications
13.11.3 Longyan Tianhua Biological Technology Testosterone Injectable Sales, Revenue, Price and Gross Margin (2019-2024)
13.11.4 Longyan Tianhua Biological Technology Main Business Overview
13.11.5 Longyan Tianhua Biological Technology Latest Developments
14 RESEARCH FINDINGS AND CONCLUSION
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Testosterone Injectable Annual Sales 2019-2030
2.1.2 World Current & Future Analysis for Testosterone Injectable by Geographic Region, 2019, 2023 & 2030
2.1.3 World Current & Future Analysis for Testosterone Injectable by Country/Region, 2019, 2023 & 2030
2.2 Testosterone Injectable Segment by Type
2.2.1 Testosterone Cypionate
2.2.2 Testosterone Undecanoate
2.2.3 Testosterone Enanthate
2.2.4 Methyl testosterone
2.2.5 Others
2.3 Testosterone Injectable Sales by Type
2.3.1 Global Testosterone Injectable Sales Market Share by Type (2019-2024)
2.3.2 Global Testosterone Injectable Revenue and Market Share by Type (2019-2024)
2.3.3 Global Testosterone Injectable Sale Price by Type (2019-2024)
2.4 Testosterone Injectable Segment by Application
2.4.1 Hospitals
2.4.2 Homecare
2.4.3 Specialty Clinics
2.4.4 Others
2.5 Testosterone Injectable Sales by Application
2.5.1 Global Testosterone Injectable Sale Market Share by Application (2019-2024)
2.5.2 Global Testosterone Injectable Revenue and Market Share by Application (2019-2024)
2.5.3 Global Testosterone Injectable Sale Price by Application (2019-2024)
3 GLOBAL BY COMPANY
3.1 Global Testosterone Injectable Breakdown Data by Company
3.1.1 Global Testosterone Injectable Annual Sales by Company (2019-2024)
3.1.2 Global Testosterone Injectable Sales Market Share by Company (2019-2024)
3.2 Global Testosterone Injectable Annual Revenue by Company (2019-2024)
3.2.1 Global Testosterone Injectable Revenue by Company (2019-2024)
3.2.2 Global Testosterone Injectable Revenue Market Share by Company (2019-2024)
3.3 Global Testosterone Injectable Sale Price by Company
3.4 Key Manufacturers Testosterone Injectable Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Testosterone Injectable Product Location Distribution
3.4.2 Players Testosterone Injectable Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2019-2024)
3.6 New Products and Potential Entrants
3.7 Market M&A Activity & Strategy
4 WORLD HISTORIC REVIEW FOR TESTOSTERONE INJECTABLE BY GEOGRAPHIC REGION
4.1 World Historic Testosterone Injectable Market Size by Geographic Region (2019-2024)
4.1.1 Global Testosterone Injectable Annual Sales by Geographic Region (2019-2024)
4.1.2 Global Testosterone Injectable Annual Revenue by Geographic Region (2019-2024)
4.2 World Historic Testosterone Injectable Market Size by Country/Region (2019-2024)
4.2.1 Global Testosterone Injectable Annual Sales by Country/Region (2019-2024)
4.2.2 Global Testosterone Injectable Annual Revenue by Country/Region (2019-2024)
4.3 Americas Testosterone Injectable Sales Growth
4.4 APAC Testosterone Injectable Sales Growth
4.5 Europe Testosterone Injectable Sales Growth
4.6 Middle East & Africa Testosterone Injectable Sales Growth
5 AMERICAS
5.1 Americas Testosterone Injectable Sales by Country
5.1.1 Americas Testosterone Injectable Sales by Country (2019-2024)
5.1.2 Americas Testosterone Injectable Revenue by Country (2019-2024)
5.2 Americas Testosterone Injectable Sales by Type (2019-2024)
5.3 Americas Testosterone Injectable Sales by Application (2019-2024)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Testosterone Injectable Sales by Region
6.1.1 APAC Testosterone Injectable Sales by Region (2019-2024)
6.1.2 APAC Testosterone Injectable Revenue by Region (2019-2024)
6.2 APAC Testosterone Injectable Sales by Type (2019-2024)
6.3 APAC Testosterone Injectable Sales by Application (2019-2024)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 EUROPE
7.1 Europe Testosterone Injectable by Country
7.1.1 Europe Testosterone Injectable Sales by Country (2019-2024)
7.1.2 Europe Testosterone Injectable Revenue by Country (2019-2024)
7.2 Europe Testosterone Injectable Sales by Type (2019-2024)
7.3 Europe Testosterone Injectable Sales by Application (2019-2024)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Testosterone Injectable by Country
8.1.1 Middle East & Africa Testosterone Injectable Sales by Country (2019-2024)
8.1.2 Middle East & Africa Testosterone Injectable Revenue by Country (2019-2024)
8.2 Middle East & Africa Testosterone Injectable Sales by Type (2019-2024)
8.3 Middle East & Africa Testosterone Injectable Sales by Application (2019-2024)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 MANUFACTURING COST STRUCTURE ANALYSIS
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Testosterone Injectable
10.3 Manufacturing Process Analysis of Testosterone Injectable
10.4 Industry Chain Structure of Testosterone Injectable
11 MARKETING, DISTRIBUTORS AND CUSTOMER
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Testosterone Injectable Distributors
11.3 Testosterone Injectable Customer
12 WORLD FORECAST REVIEW FOR TESTOSTERONE INJECTABLE BY GEOGRAPHIC REGION
12.1 Global Testosterone Injectable Market Size Forecast by Region
12.1.1 Global Testosterone Injectable Forecast by Region (2025-2030)
12.1.2 Global Testosterone Injectable Annual Revenue Forecast by Region (2025-2030)
12.2 Americas Forecast by Country (2025-2030)
12.3 APAC Forecast by Region (2025-2030)
12.4 Europe Forecast by Country (2025-2030)
12.5 Middle East & Africa Forecast by Country (2025-2030)
12.6 Global Testosterone Injectable Forecast by Type (2025-2030)
12.7 Global Testosterone Injectable Forecast by Application (2025-2030)
13 KEY PLAYERS ANALYSIS
13.1 Clarus Therapeutics
13.1.1 Clarus Therapeutics Company Information
13.1.2 Clarus Therapeutics Testosterone Injectable Product Portfolios and Specifications
13.1.3 Clarus Therapeutics Testosterone Injectable Sales, Revenue, Price and Gross Margin (2019-2024)
13.1.4 Clarus Therapeutics Main Business Overview
13.1.5 Clarus Therapeutics Latest Developments
13.2 Bayer
13.2.1 Bayer Company Information
13.2.2 Bayer Testosterone Injectable Product Portfolios and Specifications
13.2.3 Bayer Testosterone Injectable Sales, Revenue, Price and Gross Margin (2019-2024)
13.2.4 Bayer Main Business Overview
13.2.5 Bayer Latest Developments
13.3 Endo Pharmaceuticals
13.3.1 Endo Pharmaceuticals Company Information
13.3.2 Endo Pharmaceuticals Testosterone Injectable Product Portfolios and Specifications
13.3.3 Endo Pharmaceuticals Testosterone Injectable Sales, Revenue, Price and Gross Margin (2019-2024)
13.3.4 Endo Pharmaceuticals Main Business Overview
13.3.5 Endo Pharmaceuticals Latest Developments
13.4 Eli Lilly and Company
13.4.1 Eli Lilly and Company Company Information
13.4.2 Eli Lilly and Company Testosterone Injectable Product Portfolios and Specifications
13.4.3 Eli Lilly and Company Testosterone Injectable Sales, Revenue, Price and Gross Margin (2019-2024)
13.4.4 Eli Lilly and Company Main Business Overview
13.4.5 Eli Lilly and Company Latest Developments
13.5 Kyowa Kirin International
13.5.1 Kyowa Kirin International Company Information
13.5.2 Kyowa Kirin International Testosterone Injectable Product Portfolios and Specifications
13.5.3 Kyowa Kirin International Testosterone Injectable Sales, Revenue, Price and Gross Margin (2019-2024)
13.5.4 Kyowa Kirin International Main Business Overview
13.5.5 Kyowa Kirin International Latest Developments
13.6 Viatris
13.6.1 Viatris Company Information
13.6.2 Viatris Testosterone Injectable Product Portfolios and Specifications
13.6.3 Viatris Testosterone Injectable Sales, Revenue, Price and Gross Margin (2019-2024)
13.6.4 Viatris Main Business Overview
13.6.5 Viatris Latest Developments
13.7 Novartis
13.7.1 Novartis Company Information
13.7.2 Novartis Testosterone Injectable Product Portfolios and Specifications
13.7.3 Novartis Testosterone Injectable Sales, Revenue, Price and Gross Margin (2019-2024)
13.7.4 Novartis Main Business Overview
13.7.5 Novartis Latest Developments
13.8 Pfizer
13.8.1 Pfizer Company Information
13.8.2 Pfizer Testosterone Injectable Product Portfolios and Specifications
13.8.3 Pfizer Testosterone Injectable Sales, Revenue, Price and Gross Margin (2019-2024)
13.8.4 Pfizer Main Business Overview
13.8.5 Pfizer Latest Developments
13.9 J & K Scientific
13.9.1 J & K Scientific Company Information
13.9.2 J & K Scientific Testosterone Injectable Product Portfolios and Specifications
13.9.3 J & K Scientific Testosterone Injectable Sales, Revenue, Price and Gross Margin (2019-2024)
13.9.4 J & K Scientific Main Business Overview
13.9.5 J & K Scientific Latest Developments
13.10 Beijing Coupling Technology
13.10.1 Beijing Coupling Technology Company Information
13.10.2 Beijing Coupling Technology Testosterone Injectable Product Portfolios and Specifications
13.10.3 Beijing Coupling Technology Testosterone Injectable Sales, Revenue, Price and Gross Margin (2019-2024)
13.10.4 Beijing Coupling Technology Main Business Overview
13.10.5 Beijing Coupling Technology Latest Developments
13.11 Longyan Tianhua Biological Technology
13.11.1 Longyan Tianhua Biological Technology Company Information
13.11.2 Longyan Tianhua Biological Technology Testosterone Injectable Product Portfolios and Specifications
13.11.3 Longyan Tianhua Biological Technology Testosterone Injectable Sales, Revenue, Price and Gross Margin (2019-2024)
13.11.4 Longyan Tianhua Biological Technology Main Business Overview
13.11.5 Longyan Tianhua Biological Technology Latest Developments
14 RESEARCH FINDINGS AND CONCLUSION
LIST OF TABLES
Table 1. Testosterone Injectable Annual Sales CAGR by Geographic Region (2019, 2023 & 2030) & ($ millions)
Table 2. Testosterone Injectable Annual Sales CAGR by Country/Region (2019, 2023 & 2030) & ($ millions)
Table 3. Major Players of Testosterone Cypionate
Table 4. Major Players of Testosterone Undecanoate
Table 5. Major Players of Testosterone Enanthate
Table 6. Major Players of Methyl testosterone
Table 7. Major Players of Others
Table 8. Global Testosterone Injectable Sales by Type (2019-2024) & (K Units)
Table 9. Global Testosterone Injectable Sales Market Share by Type (2019-2024)
Table 10. Global Testosterone Injectable Revenue by Type (2019-2024) & ($ million)
Table 11. Global Testosterone Injectable Revenue Market Share by Type (2019-2024)
Table 12. Global Testosterone Injectable Sale Price by Type (2019-2024) & (US$/Unit)
Table 13. Global Testosterone Injectable Sale by Application (2019-2024) & (K Units)
Table 14. Global Testosterone Injectable Sale Market Share by Application (2019-2024)
Table 15. Global Testosterone Injectable Revenue by Application (2019-2024) & ($ million)
Table 16. Global Testosterone Injectable Revenue Market Share by Application (2019-2024)
Table 17. Global Testosterone Injectable Sale Price by Application (2019-2024) & (US$/Unit)
Table 18. Global Testosterone Injectable Sales by Company (2019-2024) & (K Units)
Table 19. Global Testosterone Injectable Sales Market Share by Company (2019-2024)
Table 20. Global Testosterone Injectable Revenue by Company (2019-2024) & ($ millions)
Table 21. Global Testosterone Injectable Revenue Market Share by Company (2019-2024)
Table 22. Global Testosterone Injectable Sale Price by Company (2019-2024) & (US$/Unit)
Table 23. Key Manufacturers Testosterone Injectable Producing Area Distribution and Sales Area
Table 24. Players Testosterone Injectable Products Offered
Table 25. Testosterone Injectable Concentration Ratio (CR3, CR5 and CR10) & (2019-2024)
Table 26. New Products and Potential Entrants
Table 27. Market M&A Activity & Strategy
Table 28. Global Testosterone Injectable Sales by Geographic Region (2019-2024) & (K Units)
Table 29. Global Testosterone Injectable Sales Market Share Geographic Region (2019-2024)
Table 30. Global Testosterone Injectable Revenue by Geographic Region (2019-2024) & ($ millions)
Table 31. Global Testosterone Injectable Revenue Market Share by Geographic Region (2019-2024)
Table 32. Global Testosterone Injectable Sales by Country/Region (2019-2024) & (K Units)
Table 33. Global Testosterone Injectable Sales Market Share by Country/Region (2019-2024)
Table 34. Global Testosterone Injectable Revenue by Country/Region (2019-2024) & ($ millions)
Table 35. Global Testosterone Injectable Revenue Market Share by Country/Region (2019-2024)
Table 36. Americas Testosterone Injectable Sales by Country (2019-2024) & (K Units)
Table 37. Americas Testosterone Injectable Sales Market Share by Country (2019-2024)
Table 38. Americas Testosterone Injectable Revenue by Country (2019-2024) & ($ millions)
Table 39. Americas Testosterone Injectable Sales by Type (2019-2024) & (K Units)
Table 40. Americas Testosterone Injectable Sales by Application (2019-2024) & (K Units)
Table 41. APAC Testosterone Injectable Sales by Region (2019-2024) & (K Units)
Table 42. APAC Testosterone Injectable Sales Market Share by Region (2019-2024)
Table 43. APAC Testosterone Injectable Revenue by Region (2019-2024) & ($ millions)
Table 44. APAC Testosterone Injectable Sales by Type (2019-2024) & (K Units)
Table 45. APAC Testosterone Injectable Sales by Application (2019-2024) & (K Units)
Table 46. Europe Testosterone Injectable Sales by Country (2019-2024) & (K Units)
Table 47. Europe Testosterone Injectable Revenue by Country (2019-2024) & ($ millions)
Table 48. Europe Testosterone Injectable Sales by Type (2019-2024) & (K Units)
Table 49. Europe Testosterone Injectable Sales by Application (2019-2024) & (K Units)
Table 50. Middle East & Africa Testosterone Injectable Sales by Country (2019-2024) & (K Units)
Table 51. Middle East & Africa Testosterone Injectable Revenue Market Share by Country (2019-2024)
Table 52. Middle East & Africa Testosterone Injectable Sales by Type (2019-2024) & (K Units)
Table 53. Middle East & Africa Testosterone Injectable Sales by Application (2019-2024) & (K Units)
Table 54. Key Market Drivers & Growth Opportunities of Testosterone Injectable
Table 55. Key Market Challenges & Risks of Testosterone Injectable
Table 56. Key Industry Trends of Testosterone Injectable
Table 57. Testosterone Injectable Raw Material
Table 58. Key Suppliers of Raw Materials
Table 59. Testosterone Injectable Distributors List
Table 60. Testosterone Injectable Customer List
Table 61. Global Testosterone Injectable Sales Forecast by Region (2025-2030) & (K Units)
Table 62. Global Testosterone Injectable Revenue Forecast by Region (2025-2030) & ($ millions)
Table 63. Americas Testosterone Injectable Sales Forecast by Country (2025-2030) & (K Units)
Table 64. Americas Testosterone Injectable Annual Revenue Forecast by Country (2025-2030) & ($ millions)
Table 65. APAC Testosterone Injectable Sales Forecast by Region (2025-2030) & (K Units)
Table 66. APAC Testosterone Injectable Annual Revenue Forecast by Region (2025-2030) & ($ millions)
Table 67. Europe Testosterone Injectable Sales Forecast by Country (2025-2030) & (K Units)
Table 68. Europe Testosterone Injectable Revenue Forecast by Country (2025-2030) & ($ millions)
Table 69. Middle East & Africa Testosterone Injectable Sales Forecast by Country (2025-2030) & (K Units)
Table 70. Middle East & Africa Testosterone Injectable Revenue Forecast by Country (2025-2030) & ($ millions)
Table 71. Global Testosterone Injectable Sales Forecast by Type (2025-2030) & (K Units)
Table 72. Global Testosterone Injectable Revenue Forecast by Type (2025-2030) & ($ millions)
Table 73. Global Testosterone Injectable Sales Forecast by Application (2025-2030) & (K Units)
Table 74. Global Testosterone Injectable Revenue Forecast by Application (2025-2030) & ($ millions)
Table 75. Clarus Therapeutics Basic Information, Testosterone Injectable Manufacturing Base, Sales Area and Its Competitors
Table 76. Clarus Therapeutics Testosterone Injectable Product Portfolios and Specifications
Table 77. Clarus Therapeutics Testosterone Injectable Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 78. Clarus Therapeutics Main Business
Table 79. Clarus Therapeutics Latest Developments
Table 80. Bayer Basic Information, Testosterone Injectable Manufacturing Base, Sales Area and Its Competitors
Table 81. Bayer Testosterone Injectable Product Portfolios and Specifications
Table 82. Bayer Testosterone Injectable Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 83. Bayer Main Business
Table 84. Bayer Latest Developments
Table 85. Endo Pharmaceuticals Basic Information, Testosterone Injectable Manufacturing Base, Sales Area and Its Competitors
Table 86. Endo Pharmaceuticals Testosterone Injectable Product Portfolios and Specifications
Table 87. Endo Pharmaceuticals Testosterone Injectable Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 88. Endo Pharmaceuticals Main Business
Table 89. Endo Pharmaceuticals Latest Developments
Table 90. Eli Lilly and Company Basic Information, Testosterone Injectable Manufacturing Base, Sales Area and Its Competitors
Table 91. Eli Lilly and Company Testosterone Injectable Product Portfolios and Specifications
Table 92. Eli Lilly and Company Testosterone Injectable Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 93. Eli Lilly and Company Main Business
Table 94. Eli Lilly and Company Latest Developments
Table 95. Kyowa Kirin International Basic Information, Testosterone Injectable Manufacturing Base, Sales Area and Its Competitors
Table 96. Kyowa Kirin International Testosterone Injectable Product Portfolios and Specifications
Table 97. Kyowa Kirin International Testosterone Injectable Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 98. Kyowa Kirin International Main Business
Table 99. Kyowa Kirin International Latest Developments
Table 100. Viatris Basic Information, Testosterone Injectable Manufacturing Base, Sales Area and Its Competitors
Table 101. Viatris Testosterone Injectable Product Portfolios and Specifications
Table 102. Viatris Testosterone Injectable Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 103. Viatris Main Business
Table 104. Viatris Latest Developments
Table 105. Novartis Basic Information, Testosterone Injectable Manufacturing Base, Sales Area and Its Competitors
Table 106. Novartis Testosterone Injectable Product Portfolios and Specifications
Table 107. Novartis Testosterone Injectable Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 108. Novartis Main Business
Table 109. Novartis Latest Developments
Table 110. Pfizer Basic Information, Testosterone Injectable Manufacturing Base, Sales Area and Its Competitors
Table 111. Pfizer Testosterone Injectable Product Portfolios and Specifications
Table 112. Pfizer Testosterone Injectable Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 113. Pfizer Main Business
Table 114. Pfizer Latest Developments
Table 115. J & K Scientific Basic Information, Testosterone Injectable Manufacturing Base, Sales Area and Its Competitors
Table 116. J & K Scientific Testosterone Injectable Product Portfolios and Specifications
Table 117. J & K Scientific Testosterone Injectable Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 118. J & K Scientific Main Business
Table 119. J & K Scientific Latest Developments
Table 120. Beijing Coupling Technology Basic Information, Testosterone Injectable Manufacturing Base, Sales Area and Its Competitors
Table 121. Beijing Coupling Technology Testosterone Injectable Product Portfolios and Specifications
Table 122. Beijing Coupling Technology Testosterone Injectable Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 123. Beijing Coupling Technology Main Business
Table 124. Beijing Coupling Technology Latest Developments
Table 125. Longyan Tianhua Biological Technology Basic Information, Testosterone Injectable Manufacturing Base, Sales Area and Its Competitors
Table 126. Longyan Tianhua Biological Technology Testosterone Injectable Product Portfolios and Specifications
Table 127. Longyan Tianhua Biological Technology Testosterone Injectable Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 128. Longyan Tianhua Biological Technology Main Business
Table 129. Longyan Tianhua Biological Technology Latest Developments
Table 1. Testosterone Injectable Annual Sales CAGR by Geographic Region (2019, 2023 & 2030) & ($ millions)
Table 2. Testosterone Injectable Annual Sales CAGR by Country/Region (2019, 2023 & 2030) & ($ millions)
Table 3. Major Players of Testosterone Cypionate
Table 4. Major Players of Testosterone Undecanoate
Table 5. Major Players of Testosterone Enanthate
Table 6. Major Players of Methyl testosterone
Table 7. Major Players of Others
Table 8. Global Testosterone Injectable Sales by Type (2019-2024) & (K Units)
Table 9. Global Testosterone Injectable Sales Market Share by Type (2019-2024)
Table 10. Global Testosterone Injectable Revenue by Type (2019-2024) & ($ million)
Table 11. Global Testosterone Injectable Revenue Market Share by Type (2019-2024)
Table 12. Global Testosterone Injectable Sale Price by Type (2019-2024) & (US$/Unit)
Table 13. Global Testosterone Injectable Sale by Application (2019-2024) & (K Units)
Table 14. Global Testosterone Injectable Sale Market Share by Application (2019-2024)
Table 15. Global Testosterone Injectable Revenue by Application (2019-2024) & ($ million)
Table 16. Global Testosterone Injectable Revenue Market Share by Application (2019-2024)
Table 17. Global Testosterone Injectable Sale Price by Application (2019-2024) & (US$/Unit)
Table 18. Global Testosterone Injectable Sales by Company (2019-2024) & (K Units)
Table 19. Global Testosterone Injectable Sales Market Share by Company (2019-2024)
Table 20. Global Testosterone Injectable Revenue by Company (2019-2024) & ($ millions)
Table 21. Global Testosterone Injectable Revenue Market Share by Company (2019-2024)
Table 22. Global Testosterone Injectable Sale Price by Company (2019-2024) & (US$/Unit)
Table 23. Key Manufacturers Testosterone Injectable Producing Area Distribution and Sales Area
Table 24. Players Testosterone Injectable Products Offered
Table 25. Testosterone Injectable Concentration Ratio (CR3, CR5 and CR10) & (2019-2024)
Table 26. New Products and Potential Entrants
Table 27. Market M&A Activity & Strategy
Table 28. Global Testosterone Injectable Sales by Geographic Region (2019-2024) & (K Units)
Table 29. Global Testosterone Injectable Sales Market Share Geographic Region (2019-2024)
Table 30. Global Testosterone Injectable Revenue by Geographic Region (2019-2024) & ($ millions)
Table 31. Global Testosterone Injectable Revenue Market Share by Geographic Region (2019-2024)
Table 32. Global Testosterone Injectable Sales by Country/Region (2019-2024) & (K Units)
Table 33. Global Testosterone Injectable Sales Market Share by Country/Region (2019-2024)
Table 34. Global Testosterone Injectable Revenue by Country/Region (2019-2024) & ($ millions)
Table 35. Global Testosterone Injectable Revenue Market Share by Country/Region (2019-2024)
Table 36. Americas Testosterone Injectable Sales by Country (2019-2024) & (K Units)
Table 37. Americas Testosterone Injectable Sales Market Share by Country (2019-2024)
Table 38. Americas Testosterone Injectable Revenue by Country (2019-2024) & ($ millions)
Table 39. Americas Testosterone Injectable Sales by Type (2019-2024) & (K Units)
Table 40. Americas Testosterone Injectable Sales by Application (2019-2024) & (K Units)
Table 41. APAC Testosterone Injectable Sales by Region (2019-2024) & (K Units)
Table 42. APAC Testosterone Injectable Sales Market Share by Region (2019-2024)
Table 43. APAC Testosterone Injectable Revenue by Region (2019-2024) & ($ millions)
Table 44. APAC Testosterone Injectable Sales by Type (2019-2024) & (K Units)
Table 45. APAC Testosterone Injectable Sales by Application (2019-2024) & (K Units)
Table 46. Europe Testosterone Injectable Sales by Country (2019-2024) & (K Units)
Table 47. Europe Testosterone Injectable Revenue by Country (2019-2024) & ($ millions)
Table 48. Europe Testosterone Injectable Sales by Type (2019-2024) & (K Units)
Table 49. Europe Testosterone Injectable Sales by Application (2019-2024) & (K Units)
Table 50. Middle East & Africa Testosterone Injectable Sales by Country (2019-2024) & (K Units)
Table 51. Middle East & Africa Testosterone Injectable Revenue Market Share by Country (2019-2024)
Table 52. Middle East & Africa Testosterone Injectable Sales by Type (2019-2024) & (K Units)
Table 53. Middle East & Africa Testosterone Injectable Sales by Application (2019-2024) & (K Units)
Table 54. Key Market Drivers & Growth Opportunities of Testosterone Injectable
Table 55. Key Market Challenges & Risks of Testosterone Injectable
Table 56. Key Industry Trends of Testosterone Injectable
Table 57. Testosterone Injectable Raw Material
Table 58. Key Suppliers of Raw Materials
Table 59. Testosterone Injectable Distributors List
Table 60. Testosterone Injectable Customer List
Table 61. Global Testosterone Injectable Sales Forecast by Region (2025-2030) & (K Units)
Table 62. Global Testosterone Injectable Revenue Forecast by Region (2025-2030) & ($ millions)
Table 63. Americas Testosterone Injectable Sales Forecast by Country (2025-2030) & (K Units)
Table 64. Americas Testosterone Injectable Annual Revenue Forecast by Country (2025-2030) & ($ millions)
Table 65. APAC Testosterone Injectable Sales Forecast by Region (2025-2030) & (K Units)
Table 66. APAC Testosterone Injectable Annual Revenue Forecast by Region (2025-2030) & ($ millions)
Table 67. Europe Testosterone Injectable Sales Forecast by Country (2025-2030) & (K Units)
Table 68. Europe Testosterone Injectable Revenue Forecast by Country (2025-2030) & ($ millions)
Table 69. Middle East & Africa Testosterone Injectable Sales Forecast by Country (2025-2030) & (K Units)
Table 70. Middle East & Africa Testosterone Injectable Revenue Forecast by Country (2025-2030) & ($ millions)
Table 71. Global Testosterone Injectable Sales Forecast by Type (2025-2030) & (K Units)
Table 72. Global Testosterone Injectable Revenue Forecast by Type (2025-2030) & ($ millions)
Table 73. Global Testosterone Injectable Sales Forecast by Application (2025-2030) & (K Units)
Table 74. Global Testosterone Injectable Revenue Forecast by Application (2025-2030) & ($ millions)
Table 75. Clarus Therapeutics Basic Information, Testosterone Injectable Manufacturing Base, Sales Area and Its Competitors
Table 76. Clarus Therapeutics Testosterone Injectable Product Portfolios and Specifications
Table 77. Clarus Therapeutics Testosterone Injectable Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 78. Clarus Therapeutics Main Business
Table 79. Clarus Therapeutics Latest Developments
Table 80. Bayer Basic Information, Testosterone Injectable Manufacturing Base, Sales Area and Its Competitors
Table 81. Bayer Testosterone Injectable Product Portfolios and Specifications
Table 82. Bayer Testosterone Injectable Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 83. Bayer Main Business
Table 84. Bayer Latest Developments
Table 85. Endo Pharmaceuticals Basic Information, Testosterone Injectable Manufacturing Base, Sales Area and Its Competitors
Table 86. Endo Pharmaceuticals Testosterone Injectable Product Portfolios and Specifications
Table 87. Endo Pharmaceuticals Testosterone Injectable Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 88. Endo Pharmaceuticals Main Business
Table 89. Endo Pharmaceuticals Latest Developments
Table 90. Eli Lilly and Company Basic Information, Testosterone Injectable Manufacturing Base, Sales Area and Its Competitors
Table 91. Eli Lilly and Company Testosterone Injectable Product Portfolios and Specifications
Table 92. Eli Lilly and Company Testosterone Injectable Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 93. Eli Lilly and Company Main Business
Table 94. Eli Lilly and Company Latest Developments
Table 95. Kyowa Kirin International Basic Information, Testosterone Injectable Manufacturing Base, Sales Area and Its Competitors
Table 96. Kyowa Kirin International Testosterone Injectable Product Portfolios and Specifications
Table 97. Kyowa Kirin International Testosterone Injectable Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 98. Kyowa Kirin International Main Business
Table 99. Kyowa Kirin International Latest Developments
Table 100. Viatris Basic Information, Testosterone Injectable Manufacturing Base, Sales Area and Its Competitors
Table 101. Viatris Testosterone Injectable Product Portfolios and Specifications
Table 102. Viatris Testosterone Injectable Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 103. Viatris Main Business
Table 104. Viatris Latest Developments
Table 105. Novartis Basic Information, Testosterone Injectable Manufacturing Base, Sales Area and Its Competitors
Table 106. Novartis Testosterone Injectable Product Portfolios and Specifications
Table 107. Novartis Testosterone Injectable Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 108. Novartis Main Business
Table 109. Novartis Latest Developments
Table 110. Pfizer Basic Information, Testosterone Injectable Manufacturing Base, Sales Area and Its Competitors
Table 111. Pfizer Testosterone Injectable Product Portfolios and Specifications
Table 112. Pfizer Testosterone Injectable Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 113. Pfizer Main Business
Table 114. Pfizer Latest Developments
Table 115. J & K Scientific Basic Information, Testosterone Injectable Manufacturing Base, Sales Area and Its Competitors
Table 116. J & K Scientific Testosterone Injectable Product Portfolios and Specifications
Table 117. J & K Scientific Testosterone Injectable Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 118. J & K Scientific Main Business
Table 119. J & K Scientific Latest Developments
Table 120. Beijing Coupling Technology Basic Information, Testosterone Injectable Manufacturing Base, Sales Area and Its Competitors
Table 121. Beijing Coupling Technology Testosterone Injectable Product Portfolios and Specifications
Table 122. Beijing Coupling Technology Testosterone Injectable Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 123. Beijing Coupling Technology Main Business
Table 124. Beijing Coupling Technology Latest Developments
Table 125. Longyan Tianhua Biological Technology Basic Information, Testosterone Injectable Manufacturing Base, Sales Area and Its Competitors
Table 126. Longyan Tianhua Biological Technology Testosterone Injectable Product Portfolios and Specifications
Table 127. Longyan Tianhua Biological Technology Testosterone Injectable Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 128. Longyan Tianhua Biological Technology Main Business
Table 129. Longyan Tianhua Biological Technology Latest Developments
LIST OF FIGURES
Figure 1. Picture of Testosterone Injectable
Figure 2. Testosterone Injectable Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Testosterone Injectable Sales Growth Rate 2019-2030 (K Units)
Figure 7. Global Testosterone Injectable Revenue Growth Rate 2019-2030 ($ millions)
Figure 8. Testosterone Injectable Sales by Geographic Region (2019, 2023 & 2030) & ($ millions)
Figure 9. Testosterone Injectable Sales Market Share by Country/Region (2023)
Figure 10. Testosterone Injectable Sales Market Share by Country/Region (2019, 2023 & 2030)
Figure 11. Product Picture of Testosterone Cypionate
Figure 12. Product Picture of Testosterone Undecanoate
Figure 13. Product Picture of Testosterone Enanthate
Figure 14. Product Picture of Methyl testosterone
Figure 15. Product Picture of Others
Figure 16. Global Testosterone Injectable Sales Market Share by Type in 2023
Figure 17. Global Testosterone Injectable Revenue Market Share by Type (2019-2024)
Figure 18. Testosterone Injectable Consumed in Hospitals
Figure 19. Global Testosterone Injectable Market: Hospitals (2019-2024) & (K Units)
Figure 20. Testosterone Injectable Consumed in Homecare
Figure 21. Global Testosterone Injectable Market: Homecare (2019-2024) & (K Units)
Figure 22. Testosterone Injectable Consumed in Specialty Clinics
Figure 23. Global Testosterone Injectable Market: Specialty Clinics (2019-2024) & (K Units)
Figure 24. Testosterone Injectable Consumed in Others
Figure 25. Global Testosterone Injectable Market: Others (2019-2024) & (K Units)
Figure 26. Global Testosterone Injectable Sale Market Share by Application (2023)
Figure 27. Global Testosterone Injectable Revenue Market Share by Application in 2023
Figure 28. Testosterone Injectable Sales by Company in 2023 (K Units)
Figure 29. Global Testosterone Injectable Sales Market Share by Company in 2023
Figure 30. Testosterone Injectable Revenue by Company in 2023 ($ millions)
Figure 31. Global Testosterone Injectable Revenue Market Share by Company in 2023
Figure 32. Global Testosterone Injectable Sales Market Share by Geographic Region (2019-2024)
Figure 33. Global Testosterone Injectable Revenue Market Share by Geographic Region in 2023
Figure 34. Americas Testosterone Injectable Sales 2019-2024 (K Units)
Figure 35. Americas Testosterone Injectable Revenue 2019-2024 ($ millions)
Figure 36. APAC Testosterone Injectable Sales 2019-2024 (K Units)
Figure 37. APAC Testosterone Injectable Revenue 2019-2024 ($ millions)
Figure 38. Europe Testosterone Injectable Sales 2019-2024 (K Units)
Figure 39. Europe Testosterone Injectable Revenue 2019-2024 ($ millions)
Figure 40. Middle East & Africa Testosterone Injectable Sales 2019-2024 (K Units)
Figure 41. Middle East & Africa Testosterone Injectable Revenue 2019-2024 ($ millions)
Figure 42. Americas Testosterone Injectable Sales Market Share by Country in 2023
Figure 43. Americas Testosterone Injectable Revenue Market Share by Country (2019-2024)
Figure 44. Americas Testosterone Injectable Sales Market Share by Type (2019-2024)
Figure 45. Americas Testosterone Injectable Sales Market Share by Application (2019-2024)
Figure 46. United States Testosterone Injectable Revenue Growth 2019-2024 ($ millions)
Figure 47. Canada Testosterone Injectable Revenue Growth 2019-2024 ($ millions)
Figure 48. Mexico Testosterone Injectable Revenue Growth 2019-2024 ($ millions)
Figure 49. Brazil Testosterone Injectable Revenue Growth 2019-2024 ($ millions)
Figure 50. APAC Testosterone Injectable Sales Market Share by Region in 2023
Figure 51. APAC Testosterone Injectable Revenue Market Share by Region (2019-2024)
Figure 52. APAC Testosterone Injectable Sales Market Share by Type (2019-2024)
Figure 53. APAC Testosterone Injectable Sales Market Share by Application (2019-2024)
Figure 54. China Testosterone Injectable Revenue Growth 2019-2024 ($ millions)
Figure 55. Japan Testosterone Injectable Revenue Growth 2019-2024 ($ millions)
Figure 56. South Korea Testosterone Injectable Revenue Growth 2019-2024 ($ millions)
Figure 57. Southeast Asia Testosterone Injectable Revenue Growth 2019-2024 ($ millions)
Figure 58. India Testosterone Injectable Revenue Growth 2019-2024 ($ millions)
Figure 59. Australia Testosterone Injectable Revenue Growth 2019-2024 ($ millions)
Figure 60. China Taiwan Testosterone Injectable Revenue Growth 2019-2024 ($ millions)
Figure 61. Europe Testosterone Injectable Sales Market Share by Country in 2023
Figure 62. Europe Testosterone Injectable Revenue Market Share by Country (2019-2024)
Figure 63. Europe Testosterone Injectable Sales Market Share by Type (2019-2024)
Figure 64. Europe Testosterone Injectable Sales Market Share by Application (2019-2024)
Figure 65. Germany Testosterone Injectable Revenue Growth 2019-2024 ($ millions)
Figure 66. France Testosterone Injectable Revenue Growth 2019-2024 ($ millions)
Figure 67. UK Testosterone Injectable Revenue Growth 2019-2024 ($ millions)
Figure 68. Italy Testosterone Injectable Revenue Growth 2019-2024 ($ millions)
Figure 69. Russia Testosterone Injectable Revenue Growth 2019-2024 ($ millions)
Figure 70. Middle East & Africa Testosterone Injectable Sales Market Share by Country (2019-2024)
Figure 71. Middle East & Africa Testosterone Injectable Sales Market Share by Type (2019-2024)
Figure 72. Middle East & Africa Testosterone Injectable Sales Market Share by Application (2019-2024)
Figure 73. Egypt Testosterone Injectable Revenue Growth 2019-2024 ($ millions)
Figure 74. South Africa Testosterone Injectable Revenue Growth 2019-2024 ($ millions)
Figure 75. Israel Testosterone Injectable Revenue Growth 2019-2024 ($ millions)
Figure 76. Turkey Testosterone Injectable Revenue Growth 2019-2024 ($ millions)
Figure 77. GCC Countries Testosterone Injectable Revenue Growth 2019-2024 ($ millions)
Figure 78. Manufacturing Cost Structure Analysis of Testosterone Injectable in 2023
Figure 79. Manufacturing Process Analysis of Testosterone Injectable
Figure 80. Industry Chain Structure of Testosterone Injectable
Figure 81. Channels of Distribution
Figure 82. Global Testosterone Injectable Sales Market Forecast by Region (2025-2030)
Figure 83. Global Testosterone Injectable Revenue Market Share Forecast by Region (2025-2030)
Figure 84. Global Testosterone Injectable Sales Market Share Forecast by Type (2025-2030)
Figure 85. Global Testosterone Injectable Revenue Market Share Forecast by Type (2025-2030)
Figure 86. Global Testosterone Injectable Sales Market Share Forecast by Application (2025-2030)
Figure 87. Global Testosterone Injectable Revenue Market Share Forecast by Application (2025-2030)
Figure 1. Picture of Testosterone Injectable
Figure 2. Testosterone Injectable Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Testosterone Injectable Sales Growth Rate 2019-2030 (K Units)
Figure 7. Global Testosterone Injectable Revenue Growth Rate 2019-2030 ($ millions)
Figure 8. Testosterone Injectable Sales by Geographic Region (2019, 2023 & 2030) & ($ millions)
Figure 9. Testosterone Injectable Sales Market Share by Country/Region (2023)
Figure 10. Testosterone Injectable Sales Market Share by Country/Region (2019, 2023 & 2030)
Figure 11. Product Picture of Testosterone Cypionate
Figure 12. Product Picture of Testosterone Undecanoate
Figure 13. Product Picture of Testosterone Enanthate
Figure 14. Product Picture of Methyl testosterone
Figure 15. Product Picture of Others
Figure 16. Global Testosterone Injectable Sales Market Share by Type in 2023
Figure 17. Global Testosterone Injectable Revenue Market Share by Type (2019-2024)
Figure 18. Testosterone Injectable Consumed in Hospitals
Figure 19. Global Testosterone Injectable Market: Hospitals (2019-2024) & (K Units)
Figure 20. Testosterone Injectable Consumed in Homecare
Figure 21. Global Testosterone Injectable Market: Homecare (2019-2024) & (K Units)
Figure 22. Testosterone Injectable Consumed in Specialty Clinics
Figure 23. Global Testosterone Injectable Market: Specialty Clinics (2019-2024) & (K Units)
Figure 24. Testosterone Injectable Consumed in Others
Figure 25. Global Testosterone Injectable Market: Others (2019-2024) & (K Units)
Figure 26. Global Testosterone Injectable Sale Market Share by Application (2023)
Figure 27. Global Testosterone Injectable Revenue Market Share by Application in 2023
Figure 28. Testosterone Injectable Sales by Company in 2023 (K Units)
Figure 29. Global Testosterone Injectable Sales Market Share by Company in 2023
Figure 30. Testosterone Injectable Revenue by Company in 2023 ($ millions)
Figure 31. Global Testosterone Injectable Revenue Market Share by Company in 2023
Figure 32. Global Testosterone Injectable Sales Market Share by Geographic Region (2019-2024)
Figure 33. Global Testosterone Injectable Revenue Market Share by Geographic Region in 2023
Figure 34. Americas Testosterone Injectable Sales 2019-2024 (K Units)
Figure 35. Americas Testosterone Injectable Revenue 2019-2024 ($ millions)
Figure 36. APAC Testosterone Injectable Sales 2019-2024 (K Units)
Figure 37. APAC Testosterone Injectable Revenue 2019-2024 ($ millions)
Figure 38. Europe Testosterone Injectable Sales 2019-2024 (K Units)
Figure 39. Europe Testosterone Injectable Revenue 2019-2024 ($ millions)
Figure 40. Middle East & Africa Testosterone Injectable Sales 2019-2024 (K Units)
Figure 41. Middle East & Africa Testosterone Injectable Revenue 2019-2024 ($ millions)
Figure 42. Americas Testosterone Injectable Sales Market Share by Country in 2023
Figure 43. Americas Testosterone Injectable Revenue Market Share by Country (2019-2024)
Figure 44. Americas Testosterone Injectable Sales Market Share by Type (2019-2024)
Figure 45. Americas Testosterone Injectable Sales Market Share by Application (2019-2024)
Figure 46. United States Testosterone Injectable Revenue Growth 2019-2024 ($ millions)
Figure 47. Canada Testosterone Injectable Revenue Growth 2019-2024 ($ millions)
Figure 48. Mexico Testosterone Injectable Revenue Growth 2019-2024 ($ millions)
Figure 49. Brazil Testosterone Injectable Revenue Growth 2019-2024 ($ millions)
Figure 50. APAC Testosterone Injectable Sales Market Share by Region in 2023
Figure 51. APAC Testosterone Injectable Revenue Market Share by Region (2019-2024)
Figure 52. APAC Testosterone Injectable Sales Market Share by Type (2019-2024)
Figure 53. APAC Testosterone Injectable Sales Market Share by Application (2019-2024)
Figure 54. China Testosterone Injectable Revenue Growth 2019-2024 ($ millions)
Figure 55. Japan Testosterone Injectable Revenue Growth 2019-2024 ($ millions)
Figure 56. South Korea Testosterone Injectable Revenue Growth 2019-2024 ($ millions)
Figure 57. Southeast Asia Testosterone Injectable Revenue Growth 2019-2024 ($ millions)
Figure 58. India Testosterone Injectable Revenue Growth 2019-2024 ($ millions)
Figure 59. Australia Testosterone Injectable Revenue Growth 2019-2024 ($ millions)
Figure 60. China Taiwan Testosterone Injectable Revenue Growth 2019-2024 ($ millions)
Figure 61. Europe Testosterone Injectable Sales Market Share by Country in 2023
Figure 62. Europe Testosterone Injectable Revenue Market Share by Country (2019-2024)
Figure 63. Europe Testosterone Injectable Sales Market Share by Type (2019-2024)
Figure 64. Europe Testosterone Injectable Sales Market Share by Application (2019-2024)
Figure 65. Germany Testosterone Injectable Revenue Growth 2019-2024 ($ millions)
Figure 66. France Testosterone Injectable Revenue Growth 2019-2024 ($ millions)
Figure 67. UK Testosterone Injectable Revenue Growth 2019-2024 ($ millions)
Figure 68. Italy Testosterone Injectable Revenue Growth 2019-2024 ($ millions)
Figure 69. Russia Testosterone Injectable Revenue Growth 2019-2024 ($ millions)
Figure 70. Middle East & Africa Testosterone Injectable Sales Market Share by Country (2019-2024)
Figure 71. Middle East & Africa Testosterone Injectable Sales Market Share by Type (2019-2024)
Figure 72. Middle East & Africa Testosterone Injectable Sales Market Share by Application (2019-2024)
Figure 73. Egypt Testosterone Injectable Revenue Growth 2019-2024 ($ millions)
Figure 74. South Africa Testosterone Injectable Revenue Growth 2019-2024 ($ millions)
Figure 75. Israel Testosterone Injectable Revenue Growth 2019-2024 ($ millions)
Figure 76. Turkey Testosterone Injectable Revenue Growth 2019-2024 ($ millions)
Figure 77. GCC Countries Testosterone Injectable Revenue Growth 2019-2024 ($ millions)
Figure 78. Manufacturing Cost Structure Analysis of Testosterone Injectable in 2023
Figure 79. Manufacturing Process Analysis of Testosterone Injectable
Figure 80. Industry Chain Structure of Testosterone Injectable
Figure 81. Channels of Distribution
Figure 82. Global Testosterone Injectable Sales Market Forecast by Region (2025-2030)
Figure 83. Global Testosterone Injectable Revenue Market Share Forecast by Region (2025-2030)
Figure 84. Global Testosterone Injectable Sales Market Share Forecast by Type (2025-2030)
Figure 85. Global Testosterone Injectable Revenue Market Share Forecast by Type (2025-2030)
Figure 86. Global Testosterone Injectable Sales Market Share Forecast by Application (2025-2030)
Figure 87. Global Testosterone Injectable Revenue Market Share Forecast by Application (2025-2030)
